Literature DB >> 8082544

Visual dysfunction in normotensive glaucoma.

G L Trick1.   

Abstract

Color vision (desaturated D-15), contrast sensitivity (Vistech 6500) and pattern electroretinograms (transient and steady state) were measured in nine patients with diagnosed normotensive glaucoma. Results were compared to those from visually normal controls subjects (n = 73) and patients with primary open-angle glaucoma (n = 51). Patients with normotensive glaucoma exhibited significant contrast sensitivity and pattern electroretinogram deficits similar to those evident in patients with primary open-angle glaucoma. However, patients with normotensive glaucoma exhibited significantly better color vision than did patients with primary open-angle glaucoma. These results indicate that the pattern of visual impairment associated normotensive glaucoma and primary open-angle glaucoma is not identical. Different pathologic mechanisms mediating visual loss in the two diseases could explain these differences.

Entities:  

Mesh:

Year:  1993        PMID: 8082544     DOI: 10.1007/bf01371128

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  10 in total

1.  Pattern electroretinogram: an electrophysiological technique applicable to primary open-angle glaucoma and ocular hypertension.

Authors:  G L Trick
Journal:  J Glaucoma       Date:  1992       Impact factor: 2.503

2.  A comparison of the blue color mechanism in high- and low-tension glaucoma.

Authors:  Y Yamazaki; R Lakowski; S M Drance
Journal:  Ophthalmology       Date:  1989-01       Impact factor: 12.079

3.  A quantitative scoring technique for panel tests of color vision.

Authors:  A J Vingrys; P E King-Smith
Journal:  Invest Ophthalmol Vis Sci       Date:  1988-01       Impact factor: 4.799

4.  Comparison of visual field defects in the low-tension glaucomas with those in the high-tension glaucomas.

Authors:  J Caprioli; G L Spaeth
Journal:  Am J Ophthalmol       Date:  1984-06       Impact factor: 5.258

5.  Comparison of visual field defects in normal-tension glaucoma and high-tension glaucoma.

Authors:  D King; S M Drance; G Douglas; M Schulzer; K Wijsman
Journal:  Am J Ophthalmol       Date:  1986-02-15       Impact factor: 5.258

6.  Improved electrode for electroretinography.

Authors:  W W Dawson; G L Trick; C A Litzkow
Journal:  Invest Ophthalmol Vis Sci       Date:  1979-09       Impact factor: 4.799

7.  Comparison of the optic nerve head in high- and low-tension glaucoma.

Authors:  J Caprioli; G L Spaeth
Journal:  Arch Ophthalmol       Date:  1985-08

8.  Low tension glaucoma: a critical review and new material.

Authors:  R Z Levene
Journal:  Surv Ophthalmol       Date:  1980 May-Jun       Impact factor: 6.048

Review 9.  Electrophysiological and psychophysical testing of vision in glaucoma.

Authors:  I Bodis-Wollner
Journal:  Surv Ophthalmol       Date:  1989-02       Impact factor: 6.048

Review 10.  Psychophysical changes in glaucoma.

Authors:  R L Stamper
Journal:  Surv Ophthalmol       Date:  1989-02       Impact factor: 6.048

  10 in total
  5 in total

Review 1.  Acquired colour vision defects in glaucoma-their detection and clinical significance.

Authors:  M Pacheco-Cutillas; D F Edgar; A Sahraie
Journal:  Br J Ophthalmol       Date:  1999-12       Impact factor: 4.638

2.  Color axis evaluation of the Farnsworth Munsell 100-hue test in primary open-angle glaucoma and normal-pressure glaucoma.

Authors:  W M Budde; A Jünemann; M Korth
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-08       Impact factor: 3.117

3.  Pattern electroretinogram and glaucoma.

Authors:  G van Lith; P Ringens; L J de Heer
Journal:  Dev Ophthalmol       Date:  1984

4.  Pilot study of the multifocal electroretinogram in ocular hypertension.

Authors:  H H Chan; B Brown
Journal:  Br J Ophthalmol       Date:  2000-10       Impact factor: 4.638

Review 5.  Pattern electroretinogram in glaucoma.

Authors:  Lori M Ventura; Vittorio Porciatti
Journal:  Curr Opin Ophthalmol       Date:  2006-04       Impact factor: 3.761

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.